Odyssey raises $101M Series C as first immunology drugs approach the clinicnews2023-12-05T12:00:29+00:00December 5th, 2023|Endpoints News|
Seattle Children’s spins out Brainchild Bio, with Breyanzi inventor Mike Jensen as chief scientistnews2023-12-05T12:00:07+00:00December 5th, 2023|Endpoints News|
CRISPR reprioritizes CAR-T pipeline with cuts, expands into autoimmune disease as US decision for exa-cel loomsnews2023-12-05T11:53:22+00:00December 5th, 2023|Endpoints News|
Another Flagship-founded biotech shutters as Axcella liquidates, ending long Covid plansnews2023-12-05T08:21:04+00:00December 5th, 2023|Endpoints News|
Sanofi’s AI dealmaking continues with up to $140M for collaboration with Paris startup Aqemianews2023-12-05T07:00:11+00:00December 5th, 2023|Endpoints News|
Alto Neuroscience unveils efficacy signal from PhIIa MDD trial with machine learning-identified biomarkernews2023-12-04T22:00:48+00:00December 4th, 2023|Endpoints News|
23andMe said hackers accessed over five million members’ ancestry infonews2023-12-04T21:11:05+00:00December 4th, 2023|Endpoints News|
Roche’s BTK inhibitor put on partial hold over concerns about potential liver injurynews2023-12-04T20:11:23+00:00December 4th, 2023|Endpoints News|
Endo hits the pool hall with Peyronie’s disease patients for latest campaignnews2023-12-04T20:05:57+00:00December 4th, 2023|Endpoints News|
Fujifilm makes $200M manufacturing investment while Novartis pours $80M+ into China facilitynews2023-12-04T19:43:00+00:00December 4th, 2023|Endpoints News|
